BevCanna Enterprises

TILRAY NASDAQTLRY STOCK QUOTE

https://www.tilray.com/

LATEST NEWS FROM TILRAY

Tilray Stockholders Approve Proposal to Increase Authorized Shares at Special Meeting

Tilray to Participate in Barclays Global Consumer Staples Conference on September 10th, 2021

Tilray Chairman and CEO, Irwin D. Simon, Sends Shareholder Letter Mapping out $4B Revenue Plan

Tilray Announces Adjournment of Special Meeting of Stockholders to September 10, 2021

Tilray Acquires Majority Position in Amended MedMen Convertible Notes

Tilray Launches New Medical Cannabis Edibles in Canada

Tilray Announces Adjournment of Special Meeting of Stockholders to August 19, 2021

Tilray, Inc. Reports 2021 Fiscal Year and Fourth Quarter Results

Manitoba Harvest Announces New Research Partnership to Drive Innovation in Hemp and Pea Protein

New partnership to develop pea and hemp varieties for ingredient processing

Growth Oriented Cannabis Companies Are Your Best Bet; Don't Bet On The Government To Legalize Weed

Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Tilray Shareholders Vote “FOR” All Proposals at Tilray’s Upcoming Special Meeting

Tilray to Announce Fourth Quarter and Fiscal 2021 Financial Results on July 28, 2021

Leading Independent Proxy Advisory Firm ISS Recommends Tilray Shareholders Vote “FOR” All Proposals at Tilray’s Upcoming Special Meeting

Tilray’s Aphria RX GmbH Subsidiary Completes First Successful Harvest and Delivery of Medical Cannabis Grown in Germany

Tilray Introduces Its First Cross-brand Product Collaboration and Launches Canadian Craft Cannabis Brand, Broken Coast, in the U.S.

Tilray Asks Stockholders to Support Key Initiatives to Drive Strategic Growth and Strengthen Stockholder Rights

Four Cannabis Stocks for the Summer of 2021

Tilray Announces Launch of New Medical Cannabis Brand, Symbios

Tilray to Webcast Fireside Chats From Two Investor Conferences in June

Tilray to Participate in BMO Capital Markets Investor Conference

Tilray Commences Trading on the Toronto Stock Exchange Under Symbol “TLRY”

Tilray & Aphria Announce Closing of Transaction That Creates the “New” Tilray – a Global Cannabis Leader

Tilray Named to Time’s Inaugural List of the Time100 Most Influential Companies

Tilray Board of Directors Announces Approval of Amendment to Company’s Bylaws; Aphria and Tilray Announce Waiver of Charter Amendment Proposal Requirement

Special Meeting of Tilray, Inc. Stockholders Adjourned to April 30, 2021 at 11:00 a.m. Eastern Time

MAKE YOUR VOTE COUNT!: Tilray Reminds Shareholders to Vote FOR the Proposed Business Combination With Aphria Inc.

Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend Shareholders Vote FOR the Proposed Aphria and Tilray Business Combination

Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination

Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination

Tilray® Receives Approvals to Expand and Commercialize Medical Cannabis Products in New Zealand

Tilray, Inc. Reports 2020 Full Fiscal Year and Fourth Quarter Results

Tilray to Report 2020 Full Fiscal Year and Fourth Quarter Financial Results on February 17, 2021

Tilray® Announces Agreement with Grow Pharma to Import and Distribute Medical Cannabis Products in the United Kingdom

Tilray® Exports First Shipment of Medical Cannabis to Spain

Tilray® Receives the First and Only Market Authorization to Offer Medical Cannabis Products in Portugal

Tilray® Selected by French National Agency to Supply GMP-Certified Medical Cannabis Products in France